HIV molecular immunology database
Found 1 matching record:
Download this epitope record as JSON.
HXB2 Location | Gag(22-30) p17(22-30) DNA(853..879) |
Gag Epitope Map |
---|---|---|
Author Location | p17(22-30 SF2, HXBc2/Bal R5) | |
Epitope |
RPGGKKKKYK
|
Epitope Alignment
|
Show epitope variants | ||
Subtype | B | |
Species (MHC/HLA) | human(B7) | |
Immunogen | HIV-1 infection | |
Patient MHC/HLA | A2, A3, B15, B7, Cw3, Cw6; A29, A3, B44, B7, Cw3, Cw7; A24, A3, B7, B8, Cw7 | |
Country | United States | |
Experimental methods | Cytokine production, Degranulation, CD107a and b cell surface mobilization, Flow cytometric T-cell cytokine assay | |
Keywords | supervised treatment interruptions (STI), immunodominance, variant cross-reactivity, characterizing CD8+ T cells, drug resistance |
Daucher2008 Marybeth Daucher, David A. Price, Jason M. Brenchley, Laurie Lamoreaux, Julia A. Metcalf, Catherine Rehm, Elizabeth Nies-Kraske, Elizabeth Urban, Christian Yoder, Diane Rock, Julie Gumkowski, Michael R. Betts, Mark R. Dybul, and Daniel C. Douek. Virological Outcome after Structured Interruption of Antiretroviral Therapy for Human Immunodeficiency Virus Infection Is Associated with the Functional Profile of Virus-Specific CD8+ T Cells. J. Virol., 82(8):4102-4114, Apr 2008. PubMed ID: 18234797. Show all entries for this paper.